{
    "2021-03-29": [
        [
            {
                "time": "2020-12-31",
                "original_text": "复星医药：2020年盈利36.63亿元人民币，同比增长10.27%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "盈利",
                        "同比增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "复星医药2020年净利同比增逾一成 拟10派4.3元",
                "features": {
                    "keywords": [
                        "复星医药",
                        "净利",
                        "分红"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "复星医药(02196)授权Grand Pharma投资印度当地共同基金及债券 单日最高余额不超过印度卢比200亿元",
                "features": {
                    "keywords": [
                        "复星医药",
                        "Grand Pharma",
                        "投资",
                        "印度"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "国际投资"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "长荣海运：后续对长赐号的检查结果将决定该船是否能恢复其原定路线",
                "features": {
                    "keywords": [
                        "长荣海运",
                        "长赐号",
                        "检查结果"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "航运"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "复星医药2020年净利同比增10% 研发费用同比增长36.94％",
                "features": {
                    "keywords": [
                        "复星医药",
                        "净利",
                        "研发费用"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "研发"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-29",
                "original_text": "看好医药赛道，A 股是不够的，如何一键南下布局",
                "features": {
                    "keywords": [
                        "医药赛道",
                        "A股",
                        "南下布局"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "港股"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-29",
                "original_text": "医药行业一周观察：继续推荐成长性确定且估值合理的优质标的",
                "features": {
                    "keywords": [
                        "医药行业",
                        "成长性",
                        "估值合理"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}